U.S. Market for Uterine Fibroid Embolization Devices
Abstract:
Uterine fibroid embolization (UFE), also known as uterine artery embolization (UAE) is a radiology treatment for fibroids.
Scope of Report: This report pertains to a forecast period of 10 years (2009 – 2019) for the U.S. Market.
Report Contents
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.
Uterine fibroid embolization (UFE), also known as uterine artery embolization (UAE) is a radiology treatment for fibroids.
Scope of Report: This report pertains to a forecast period of 10 years (2009 – 2019) for the U.S. Market.
Report Contents
- Full Suite Executive Summary
- Competitor Analysis
- Identified Strategic Opportunities
- Procedures
- Market Overview by Segment
- Trend Analysis by Segment
- Market Drivers & Limiters
- Mergers & Acquisitions
- Customer Feedback & Market Monitoring
- Total Uterine Fibroid Embolization Device Market
- Microsphere Market
- PVA Particle Market
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.
U.S. MARKETS FOR GYNECOLOGICAL DEVICES
1.1 MARKET INTELLIGENCE SUITE BREAKDOWN
FULL SUITE EXECUTIVE SUMMARY
2.1 U.S. GYNECOLOGICAL DEVICE MARKET
2.2 GROWTH TRENDS BY SEGMENT
2.3 PROCEDURES
2.4 ASSISTED REPRODUCTION DEVICE MARKET
2.5 GLOBAL ENDOMETRIAL ABLATION MARKET
2.6 ENDOMETRIAL RESECTION DEVICE MARKET
2.7 UTERINE FIBROID EMBOLIZATION DEVICE MARKET
2.8 HYSTEROSCOPE MARKET
2.9 COLPOSCOPE MARKET
2.10 FEMALE STERILIZATION MARKET
2.11 FEMALE URINARY INCONTINENCE SLING MARKET
2.12 PELVIC FLOOR ELECTRICAL STIMULATION DEVICE MARKET
2.13 FLUID MANAGEMENT EQUIPMENT MARKET
2.14 PELVIC ORGAN PROLAPSE REPAIR DEVICE MARKET
2.15 HYSTEROSALPINGOGRAPHY (HSG) CATHETER MARKET
2.16 COMPETITIVE ANALYSIS
RESEARCH METHODOLOGY
3.1 RESEARCH SCOPE
3.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
PROCEDURES
4.1 ASSISTED REPRODUCTION PROCEDURES
4.1.1 U.S. Birth Rates
4.1.2 Hysteroscopy Procedures
4.1.3 Hysterectomy Procedures
4.1.4 Pelvic Floor Prolapse Procedures
4.1.5 Endometrial Resection Procedures
4.1.6 Global Endometrial Ablation Procedures
4.1.7 HSG and SIS Procedures
4.1.8 Myomectomy Procedures
4.1.9 Ovarian Cancer Incidence
UTERINE FIBROID EMBOLIZATION DEVICE MARKET
5.1 INTRODUCTION
5.2 MARKET OVERVIEW
5.3 MARKET ANALYSIS & FORECAST
5.3.1 Total Uterine Fibroid Embolization Device Market
5.3.2 Microsphere Market
5.3.3 PVA Particle Market
5.4 DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE ANALYSIS
ABBREVIATIONS
1.1 MARKET INTELLIGENCE SUITE BREAKDOWN
FULL SUITE EXECUTIVE SUMMARY
2.1 U.S. GYNECOLOGICAL DEVICE MARKET
2.2 GROWTH TRENDS BY SEGMENT
2.3 PROCEDURES
2.4 ASSISTED REPRODUCTION DEVICE MARKET
2.5 GLOBAL ENDOMETRIAL ABLATION MARKET
2.6 ENDOMETRIAL RESECTION DEVICE MARKET
2.7 UTERINE FIBROID EMBOLIZATION DEVICE MARKET
2.8 HYSTEROSCOPE MARKET
2.9 COLPOSCOPE MARKET
2.10 FEMALE STERILIZATION MARKET
2.11 FEMALE URINARY INCONTINENCE SLING MARKET
2.12 PELVIC FLOOR ELECTRICAL STIMULATION DEVICE MARKET
2.13 FLUID MANAGEMENT EQUIPMENT MARKET
2.14 PELVIC ORGAN PROLAPSE REPAIR DEVICE MARKET
2.15 HYSTEROSALPINGOGRAPHY (HSG) CATHETER MARKET
2.16 COMPETITIVE ANALYSIS
RESEARCH METHODOLOGY
3.1 RESEARCH SCOPE
3.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
PROCEDURES
4.1 ASSISTED REPRODUCTION PROCEDURES
4.1.1 U.S. Birth Rates
4.1.2 Hysteroscopy Procedures
4.1.3 Hysterectomy Procedures
4.1.4 Pelvic Floor Prolapse Procedures
4.1.5 Endometrial Resection Procedures
4.1.6 Global Endometrial Ablation Procedures
4.1.7 HSG and SIS Procedures
4.1.8 Myomectomy Procedures
4.1.9 Ovarian Cancer Incidence
UTERINE FIBROID EMBOLIZATION DEVICE MARKET
5.1 INTRODUCTION
5.2 MARKET OVERVIEW
5.3 MARKET ANALYSIS & FORECAST
5.3.1 Total Uterine Fibroid Embolization Device Market
5.3.2 Microsphere Market
5.3.3 PVA Particle Market
5.4 DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE ANALYSIS
ABBREVIATIONS
